Name
XOLAIR - (UK)
Ingredients/Formulations
[OMALIZUMAB]
Composition
INJ - 150-MG VIAL
Dosage Form
INJ
Dosage Remarks
INJ - BY SUBCUTANEOUS INJECTION, ACCORDING TO IMMUNOGLOBULIN E CONCENTRATION AND BODY-WEIGHT, 150 TO 375 MG IS ADMINISTERED SC EVERY 2 OR 4 WEEKS. CONSULT PRODUCT LITERATURE; CHILD UNDER 12 YEARS, NOT RECOMMENDED
Manufacturer Name
NOVARTIS
Group Name
[ANTIALLERGIC] , [MONOCLONAL ANTIBODY]
Alternate Brands
Brand Interaction
Brand Safety